{"title":"Aumento della biodisponibilità dell’insulina, somministrata per via orale, grazie a nuove nanoparticelle LDH-DCA-HA","authors":"","doi":"10.30682/ildia2201e","DOIUrl":"https://doi.org/10.30682/ildia2201e","url":null,"abstract":"","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132015159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Insulin pumps, or systems for Continuous Subcutaneous Insulin In-fusion (CSII), have changed from rudimentary devices with limited dosing flexibility to “smart” systems able to modulate insulin administration with greater flexibility and accuracy. The combination of insulin pump, continuous glucose monitoring and control algorithm now allows the automatic administration of insulin with an efficacy in glucose control never achieved previously. We review here the evolution in technology that has made possible this big advance in the care of diabetes.
{"title":"La terapia con microinfusore: stato dell’arte","authors":"Daniela Bruttomesso","doi":"10.30682/ildia2201g","DOIUrl":"https://doi.org/10.30682/ildia2201g","url":null,"abstract":"Insulin pumps, or systems for Continuous Subcutaneous Insulin In-fusion (CSII), have changed from rudimentary devices with limited dosing flexibility to “smart” systems able to modulate insulin administration with greater flexibility and accuracy. The combination of insulin pump, continuous glucose monitoring and control algorithm now allows the automatic administration of insulin with an efficacy in glucose control never achieved previously. We review here the evolution in technology that has made possible this big advance in the care of diabetes.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127519941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Scaramuzza, Valentino Cherubini, F. Lombardo, I. Rabbone
In Italy, it is estimated there are about 25,000 children and adolescents with type 1 diabetes between 0 and 18 years, most of whom using electronic devices for blood glucose control. Among these many have chosen a sensor for measuring blood glucose, often integrated, or combined with an insulin pump, preferably included in (advanced) hybrid closed-loop systems, that increasingly resemble artificial pancreases. This technology has seen an enormous progress in the last two decades, making these tools fundamental for improving glycemic control and the quality of life of patients with diabetes and their families. However, major challenges remain, including cybersecurity vulnerability, cost, and accessibility, with a substantial geographical variation in access to diabetes technologies. The hope is that the very recent guidelines of SID, AMD and SIEDP will help to rationalize and improve access to available technologies.
{"title":"Il ruolo della tecnologia nella gestione del bambino e dell’adolescente con diabete di tipo 1","authors":"A. Scaramuzza, Valentino Cherubini, F. Lombardo, I. Rabbone","doi":"10.30682/ildia2201h","DOIUrl":"https://doi.org/10.30682/ildia2201h","url":null,"abstract":"In Italy, it is estimated there are about 25,000 children and adolescents with type 1 diabetes between 0 and 18 years, most of whom using electronic devices for blood glucose control. Among these many have chosen a sensor for measuring blood glucose, often integrated, or combined with an insulin pump, preferably included in (advanced) hybrid closed-loop systems, that increasingly resemble artificial pancreases. This technology has seen an enormous progress in the last two decades, making these tools fundamental for improving glycemic control and the quality of life of patients with diabetes and their families. However, major challenges remain, including cybersecurity vulnerability, cost, and accessibility, with a substantial geographical variation in access to diabetes technologies. The hope is that the very recent guidelines of SID, AMD and SIEDP will help to rationalize and improve access to available technologies.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132215348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Geremia B. Bolli, Francesca Porcellati, P. Lucidi, Carmine G. Fanelli
It was January 23, 1922, when the first successful subcutaneous injection of a pancreatic extract, prepared by Banting and purified by Collip, was administered to Leonard Thompson, a young boy in diabetic ketoacidosis, at the Toronto General Hospital. That day is the birth of insulin therapy which over the years has saved tens of millions of lives of people. Animal extracted insulin has been continuously purified until human insulin and the insulin analogs have been obtained with the rDNA technique to substitute insulin according to physiology. Today basal-bolus insulin therapy in type 1 diabetes, and basal insulin in type 2 (possibly in combination with GLP-1 RA) remain the consolidated gold standards of insulin therapy in diabetes.
{"title":"23 gennaio 2022: 100 anni fa il miracolo della terapia insulinica che continua oggi","authors":"Geremia B. Bolli, Francesca Porcellati, P. Lucidi, Carmine G. Fanelli","doi":"10.30682/ildia2201a","DOIUrl":"https://doi.org/10.30682/ildia2201a","url":null,"abstract":"It was January 23, 1922, when the first successful subcutaneous injection of a pancreatic extract, prepared by Banting and purified by Collip, was administered to Leonard Thompson, a young boy in diabetic ketoacidosis, at the Toronto General Hospital. That day is the birth of insulin therapy which over the years has saved tens of millions of lives of people. Animal extracted insulin has been continuously purified until human insulin and the insulin analogs have been obtained with the rDNA technique to substitute insulin according to physiology. Today basal-bolus insulin therapy in type 1 diabetes, and basal insulin in type 2 (possibly in combination with GLP-1 RA) remain the consolidated gold standards of insulin therapy in diabetes.","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"63 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133643745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prevalenza di depressione e ansia in soggetti adulti con malattia cardiovascolare e diabete 1995-2019: dati degli studi norvegesi HUNT","authors":"Marta Letizia Hribal","doi":"10.30682/ildia2103e","DOIUrl":"https://doi.org/10.30682/ildia2103e","url":null,"abstract":"","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134175122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"La tecnologia nella gestione della terapia nutrizionale: considerazioni attuali e prospettive future","authors":"","doi":"10.30682/ildia2103g","DOIUrl":"https://doi.org/10.30682/ildia2103g","url":null,"abstract":"","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131493356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Education Ph.D., Economics, University of Nevada-Reno, Reno, NV, 2021 Advisors: Frank M. Fossen and Mark W. Nichols M.Sc., Economics, University of Nevada-Reno, Reno, NV, 2019 B.Sc., Industrial Engineering, Southern Illinois University Edwardsville, IL, 2016 (dual degree) Minor: Mathematics B.Sc., Industrial Engineering, Istanbul Technical University, Istanbul, Turkey, 2016 (dual degree) High School Certificate, Robert W. Traip Academy, Kittery, ME, 2012
指导老师:Frank M. Fossen和Mark W. Nichols文学硕士，经济学，内华达州里诺市内华达大学里诺分校，内华达州里诺市，2019年，工业工程，南伊利诺伊大学爱德华兹维尔，伊利诺伊州，2016年(双学位)辅修:数学文学学士，工业工程，伊斯坦布尔技术大学，土耳其，2016年(双学位)高中毕业证书，罗伯特W.特里普学院，基特里，缅因州，2012年
{"title":"2021","authors":"Nichola Johnson, B. Springer","doi":"10.30682/ildia2101","DOIUrl":"https://doi.org/10.30682/ildia2101","url":null,"abstract":"Education Ph.D., Economics, University of Nevada-Reno, Reno, NV, 2021 Advisors: Frank M. Fossen and Mark W. Nichols M.Sc., Economics, University of Nevada-Reno, Reno, NV, 2019 B.Sc., Industrial Engineering, Southern Illinois University Edwardsville, IL, 2016 (dual degree) Minor: Mathematics B.Sc., Industrial Engineering, Istanbul Technical University, Istanbul, Turkey, 2016 (dual degree) High School Certificate, Robert W. Traip Academy, Kittery, ME, 2012","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124199842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Neuropatia diabetica dolorosa e depressione: oltre una semplice coesistenza per capire e trattare il dolore","authors":"","doi":"10.30682/ildia2103d","DOIUrl":"https://doi.org/10.30682/ildia2103d","url":null,"abstract":"","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133028125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Differenze di genere nel diabete mellito di tipo 1 e di tipo 2: i dati italiani","authors":"","doi":"10.30682/ildia2103a","DOIUrl":"https://doi.org/10.30682/ildia2103a","url":null,"abstract":"","PeriodicalId":119243,"journal":{"name":"Il Diabete","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114759512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：